Coldstream Capital Management’s Pharming Group PHAR Stock Holding History

Coldstream Capital Management’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-106	Closed	-$887	–	2715
2025 Q1	$887	Buy	+106	New	+$950	﹤0.01%	3215

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NSG

Nalls Sherbakoff Group Knoxville, Tennessee $139M AUM 21.16% 1-Year Est. Return

Coldstream Capital Management's PHAR Position: Q2 2025 in Review

Coldstream Capital Management sold out of Pharming Group (PHAR) in Q2 2025, closing a stake of 106 shares — an estimated $887 sold.

Coldstream Capital Management first reported a position in PHAR in Q1 2025 and held it in 1 quarter. The position peaked at $887 in Q1 2025. 4 funds tracked by Wall St. Rank hold PHAR as of Q2 2025.

Coldstream Capital Management reported no remaining Pharming Group position as of Q2 2025 after selling out during the quarter.
Coldstream Capital Management sold 106 Pharming Group shares in Q2 2025, an estimated $887.
Coldstream Capital Management first reported a position in Pharming Group in Q1 2025 and held it in 1 quarter.
Coldstream Capital Management's Pharming Group position peaked at $887 in Q1 2025.
4 funds tracked by Wall St. Rank held Pharming Group as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.